These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
3. Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity. Li J; Chen J; Li X; Qian Y Biochem Biophys Res Commun; 2017 Apr; 485(3):606-613. PubMed ID: 28238782 [TBL] [Abstract][Full Text] [Related]
4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
5. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen. An LL; Whitton JL J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365 [TBL] [Abstract][Full Text] [Related]
7. New viral vectors for infectious diseases and cancer. Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065 [TBL] [Abstract][Full Text] [Related]
8. Applications and challenges of multivalent recombinant vaccines. Naim HY Hum Vaccin Immunother; 2013 Mar; 9(3):457-61. PubMed ID: 23249651 [TBL] [Abstract][Full Text] [Related]
9. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection. Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
11. Recombinant vaccine delivery systems and encoded vaccines. Stover CK Curr Opin Immunol; 1994 Aug; 6(4):568-71. PubMed ID: 7946044 [TBL] [Abstract][Full Text] [Related]
17. Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model. Munang'andu HM; Fredriksen BN; Mutoloki S; Brudeseth B; Kuo TY; Marjara IS; Dalmo RA; Evensen Ø Vaccine; 2012 Jun; 30(27):4007-16. PubMed ID: 22537985 [TBL] [Abstract][Full Text] [Related]
18. Pre-existing immunity against vaccine vectors--friend or foe? Saxena M; Van TTH; Baird FJ; Coloe PJ; Smooker PM Microbiology (Reading); 2013 Jan; 159(Pt 1):1-11. PubMed ID: 23175507 [TBL] [Abstract][Full Text] [Related]
19. The impact of new technologies on vaccine development. Winther MD; Dougan G Biotechnol Genet Eng Rev; 1984; 2():1-39. PubMed ID: 6085856 [TBL] [Abstract][Full Text] [Related]
20. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]